Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • FEBRUARY 2021 Issue has been successfully launched on 1 February 2021.



Mohammedsufiyan*, Dr. T. Vithya, Dr. A. R. Bhatt, Dr. Shankar Prasad and Dr. Shobha Rani R. H.


Vogt-Koyanagi-Harada(VKH) disease is a bilateral, chronic, diffuse granulomatous panuveitis typically characterised by serous retinal detachment and frequently associated with neurological (meningitis), auditory, and dermatological alterations. Annual incidence is estimated at 1/400,000. The condition predominantly affects young women and individuals with darker pigmentation (those of Asian, Hispanic, or Native American origin).[1] A 19 years old girl was admitted to MICU of a tertiary care hospital with the complaints of blurred vision in both eyes, vomiting 3 episodes, headache, fever, epigastric pain and provisionally diagnosed as VKH. Her history revealed that she consulted Retinal surgeon clinic before coming to hospital and funduscopy was done which showed sub retinal fluid (SRF) ++, multiple pockets present which are suggestive features of VKH syndrome. Retinal Surgeon have advised for Hb, TC, ESR, Urine routine, BUN, Serum creatinine, Angiotensin Converting Enzyme level- serum, RBS, FBS and chest x ray and advised pred. forte eye drops (1drop -1 horly)in both eyes. She was treated with IV fluids, anti-emetics, IV Methylprednisolone and other supportive measures. Patient improved symptomatically discharged in a stable condition with Multivitamin, Prednisolone PO 60 mg, Pantoprazole PO 40 mg and Paracetamol 650 mg.

Keywords: Vogt-Koyanagi-Harada, Panuveitis, Meningitis, Prednisolone.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More